Johnson & Johnson

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Johnson & Johnson
TickerJNJ
CIK #0000200406
CUSIP478160104
SectorLife Sciences - Pharmaceutical Preparations
AddressOne Johnson & Johnson Plz, New Brunswick, NJ 08933
Source [EDGAR]
CIK Filing 2011 - 2025
[0000200406] 10-K
[0000200406] 10-Q
[0000200406] 13F-HR
[0000200406] 13F-NT
[0000200406] 3
[0000200406] 4
[0000200406] 5
[0000200406] 8-K
[0000200406] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Johnson & Johnson Rapport Therapeutics Inc [2024-10-18] 6.8
Johnson & Johnson Rallybio Corp [2024-07-30] 8.8
Johnson & Johnson Contineum Therapeutics Inc [2024-04-10] 10.7
Johnson & Johnson Kenvue Inc [2024-01-24] 0.5
Johnson & Johnson CVRX Inc [2022-02-07] 19.6
State Street Corp Johnson & Johnson [2021-02-12] 5.47
Johnson & Johnson Fusion Pharmaceuticals Inc [2020-07-06] 0.0
State Street Corp Johnson & Johnson [2020-02-13] 5.77
Johnson & Johnson BiomX Inc [2019-11-26] 0.3
Johnson & Johnson MeiraGTx Holdings PLC [2019-03-04] 8.7
State Street Corp Johnson & Johnson [2019-02-13] 5.7
Johnson & Johnson Provention Bio Inc [2019-01-22] 6.4
Johnson & Johnson PhaseBio Pharmaceuticals Inc [2019-01-22] 6.6
State Street Corp Johnson & Johnson [2018-02-14] 5.81
State Street Corp Johnson & Johnson [2017-02-07] 5.65
Johnson & Johnson Merus NV [2017-01-18] 7.4
Johnson & Johnson Tracon Pharmaceuticals Inc [2016-10-31] 6.4
Johnson & Johnson Protagonist Therapeutics Inc [2016-08-19] 15.0
State Street Corp Johnson & Johnson [2016-02-16] 5.4
Johnson & Johnson Aduro Biotech Inc [2016-02-12] 6.2
Johnson & Johnson Catalyst Biosciences Inc [2015-08-28] 0.0
Johnson & Johnson Achillion Pharmaceuticals Inc [2015-07-07] 15.6
State Street Corp Johnson & Johnson [2015-02-12] 5.7
Vanguard Group Inc Johnson & Johnson [2015-02-10] 5.85
Johnson & Johnson Aquinox Pharmaceuticals Inc [2015-02-06] 15.1
Johnson & Johnson GI Dynamics Inc [2015-02-06] 6.0
Johnson & Johnson Nevro Corp [2015-02-05] 12.4
Johnson & Johnson Aldeyra Therapeutics Inc [2015-02-05] 31.4
Johnson & Johnson Macrogenics Inc [2015-02-05] 6.5
Johnson & Johnson Genocea Biosciences Inc [2015-02-05] 8.0
Johnson & Johnson Minerva Neurosciences Inc [2014-07-17] 18.0
State Street Corp Johnson & Johnson [2014-02-03] 5.7
Johnson & Johnson Prothena Corp PLC [2013-02-13] 14.82
State Street Corp Johnson & Johnson [2013-02-11] 5.5
State Street Corp Johnson & Johnson [2012-02-09] 5.1
Form 3/4/5 Filer 2011 - 2025
Johnson & Johnson
Wolk Joseph J
Reed John C
Pinto Daniel E
Woods Eugene A.
Hewson Marillyn A
Weinberger Mark A
McClellan Mark B.
Beckerle Mary C
Doudna Jennifer A
Joly Hubert
West Nadja
Johnson Paula A
Duato Joaquin
Decker Robert J
Taubert Jennifer L
Swanson James D.
Schmid Timothy
Mulholland Kristen
Forminard Elizabeth
Broadhurst Vanessa
Wengel Kathryn E
Davis D Scott
Adamczyk Darius
Mulcahy Anne M
Contineum Therapeutics, Inc.
Johnson & Johnson Innovation - JJDC, Inc.
CVRx, Inc.
Fasolo Peter
Hait William
McEvoy Ashley
Kenvue Inc.
Washington A. Eugene
Mongon Thibaut
Gorsky Alex
MeiraGTx Holdings plc
Prince Charles
Williams Ronald A
Davis Ian
Mammen Mathai
Ullmann Michael H
Stoffels Paulus
Sneed Michael E
Fusion Pharmaceuticals Inc.
Perez William D
Mesquita Jorge S.
Kapusta Ronald A
Provention Bio, Inc.
Inspire Medical Systems, Inc.
Caruso Dominic J
Peterson Sandra E
Achillion Pharmaceuticals Inc
Minerva Neurosciences, Inc.
Pruden Gary J
Lindquist Susan L
Protagonist Therapeutics, Inc
Nevro Corp
Coleman Mary Sue
Neurogene Inc.
Mullin Leo F
Cullen James
Cosgrove Stephen J
Aldeyra Therapeutics, Inc.
Johns Michael M E
Genocea Biosciences Inc
Satcher David
Weldon William C
Deyo Russell C
McCoy Sherilyn S
Universal Biosensors Inc
Form 13F Holdings
Firm Period DFND Voting Shares
Vanguard Group Inc [2025-06-30] SOLE 0 225,613,998
BlackRock, Inc. [2025-06-30] SOLE 185,159,338 203,849,282
State Street Corp [2025-06-30] DFND 64,121,213 132,797,335
Geode Capital Management LLC [2025-06-30] DFND 60,555,635 60,609,476
JPMorgan Chase & Co [2025-06-30] DFND 47,268,980 55,712,975
Morgan Stanley [2025-06-30] DFND 18,702,473 46,984,867
Norges Bank [2025-06-30] SOLE 31,929,124 31,929,124
Bank of America Corp /DE/ [2025-06-30] DFND 6,735,955 28,296,753
Northern Trust Corp [2025-06-30] DFND 26,354,742 26,703,683
Wellington Management Group LLP [2025-06-30] DFND 0 24,876,538
Bank of New York Mellon Corp [2025-06-30] DFND 19,548,640 23,156,971
State Farm Mutual Automobile Insurance Co [2025-06-30] SOLE 21,832,800 21,832,800
Legal & General Group Plc [2025-06-30] DFND 17,276,331 18,917,274
Charles Schwab Investment Management Inc [2025-06-30] SOLE 18,587,330 18,793,990
Wells Fargo & Company/MN [2025-06-30] DFND 2,135,745 18,290,136
Franklin Resources Inc [2025-06-30] DFND 17,300,555 17,455,744
Dimensional Fund Advisors LP [2025-06-30] SOLE 16,157,123 16,757,236
Deutsche Bank AG [2025-06-30] DFND 7,155,723 15,653,979
Invesco Ltd. [2025-06-30] DFND 0 14,016,955
UBS Group AG [2025-06-30] DFND 5,483,202 13,738,633
FMR LLC [2025-06-30] DFND 7,262,648 13,421,475
Ameriprise Financial Inc [2025-06-30] DFND 0 13,200,118
Royal Bank of Canada [2025-06-30] DFND 12,063,827 13,083,046
Massachusetts Financial Services Co /MA/ [2025-06-30] SOLE 12,572,304 12,679,600
Goldman Sachs Group Inc [2025-06-30] DFND 11,604,821 12,474,859
Vanguard Group Inc [2025-06-30] DFND 16,023 11,433,861
Amundi [2025-06-30] DFND 10,607,433 11,191,098
State Farm Mutual Automobile Insurance Co [2025-06-30] DFND 9,842,692 9,842,692
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] DFND 5,737,974 9,598,355
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME [2025-06-30] SOLE 6,581,916 9,541,040
Prev | Page 4 | Next
Terms | Privacy | Guide
tony@aum13f.com